Symbols

AGL

agilon health·NYSE

--(--)

AGL fundamentals

AGL Q4 2025 Earnings

agilon health (AGL) released its earnings on Feb 25, 2026: revenue was 1.57B (YoY +3.09%), beat estimates; EPS was -0.46 (YoY -76.92%), missed estimates.

Revenue / YoY

1.57B

+3.09%

EPS / YoY

-0.46

-76.92%

Report date

Feb 25, 2026

AGL Earnings Call Summary for Q4,2025

2026 Financial Reset: Targets $300-350M medical margin, breakeven adj. EBITDA, and 7.5% cost trend.
Strategic Restructuring: Exited 50,000 unprofitable members, 25,000 moved to fee-for-service with upside.
Clinical Impact: CHF pathways reduce inpatient costs, AI-driven risk ID improves margin by 40bps.
CMS Risk Mitigation: BOI program 99%+ accurate, minimal exposure to unlinked coding.
Quality Growth: 2026 quality incentive opportunity >$100M, 4.2+ star rating target.

Earnings

EPS

Revenue

Revenue & Expenses

AGL has released its 2025 Q4 earnings report, with revenue of 1.57B, reflecting a YoY change of 3.09%, and net profit of -188.88M, showing a YoY change of -78.54%. The Sankey diagram below clearly presents AGL's revenue sources and cost distribution.

Key Indicators

agilon health (AGL) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

agilon health (AGL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

agilon health (AGL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

agilon health (AGL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown